Tobacco Use Cessation Clinical Trial
Official title:
Smoking Cessation for Young Adults Who Binge Drink
Verified date | April 2015 |
Source | Mayo Clinic |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Federal GovernmentMayo Foundation: IRB |
Study type | Interventional |
The purpose of this study is develop and test the success of a new smoking cessation intervention that includes a component to eliminate binge drinking.
Status | Completed |
Enrollment | 41 |
Est. completion date | April 2008 |
Est. primary completion date | December 2007 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 25 Years |
Eligibility |
Inclusion Criteria: (1) Aged 18-25 years. (2) Enrolled as a student at a two or four year technical or non-technical college or university. (3) Smoked > 10 or more cigarettes per day during the past 6 months. (4) Binge drank on > 2 occasions per month during the past 3 months. Binge drinking is defined as consumption of > 5 standardized alcoholic drinks in a row for males or > 4 drinks in a row for females. (5) Able to participate fully in all aspects of the intervention and keep all scheduled appointments. (6) Willing to participate in 6 months of follow-up. (7) Willing to stop smoking and use nicotine patch therapy. (8) Willing to refrain from participating in additional smoking interventions for the duration of the study. (9) Provide written informed consent. (10) General good health as determined by screening physician or registered nurse. Exclusion Criteria: (1) Current (past 90 days) alcohol dependence as assessed by the Structured Clinical Interview for DSM-IV Axis I Disorders, Alcohol Dependence Module. (2) Current (past 12 months) non-nicotine or alcohol drug dependence as assessed by a Drug Abuse Screening Test-20 score of > 6. (3) Current elevation of depressive symptoms (past 2 weeks) that would be indicative of clinical depression as assessed by a Beck Depression Inventory-II score of > 20. (4) Current use (past 30 days) of nicotine containing medication or tobacco products other than cigarettes. (5) Current use (past 30 days) of any other smoking cessation treatment involving behavioral or pharmacological interventions. (6) Any medical condition that would preclude use of the nicotine patch including current unstable angina, recent history (past 30 days) of myocardial infarction or stroke, history of severe skin allergies, or evidence of severe chronic dermatosis. (7) Currently pregnant or breast feeding, or likely to become pregnant during the nicotine patch phase. |
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Mayo Clinic Jacksonville | Jacksonville | Florida |
United States | University of North Florida | Jacksonville | Florida |
United States | Mayo Clinic Rochester | Rochester | Minnesota |
Lead Sponsor | Collaborator |
---|---|
Mayo Clinic | National Institute on Drug Abuse (NIDA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Treatment attendance | quantified as the percentage of sessions attended, will be summarized separately for each treatment group and compared between groups using the rank sum test. One summary will be performed for the percentage of sessions attended face-to-face and a second summary will be performed for the percentage of sessions attended either face-to-face or via telephone. | week 12 and week 24 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06021652 -
Feasibility, Adoption and Efficacy of A Virtual Reality Smoking Cessation Program for Patients Undergoing Lung Cancer Screening
|
N/A | |
Completed |
NCT02735382 -
EHR-Based and Fax-Based Referral to a Tobacco Quitline: A Comparative Study
|
N/A | |
Completed |
NCT02557919 -
Families Reduce Exposure to Smoke at Home
|
N/A | |
Completed |
NCT01570595 -
Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV
|
Phase 1/Phase 2 | |
Completed |
NCT00786149 -
Improving Varenicline Adherence and Outcomes in Homeless Smokers
|
Phase 3 | |
Completed |
NCT00387946 -
Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN)
|
Phase 3 | |
Completed |
NCT00124683 -
Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1
|
Phase 2 | |
Recruiting |
NCT04610931 -
Study of the Effectiveness of a Virtual Reality Treatment in the Management of Smoking Cessation
|
N/A | |
Enrolling by invitation |
NCT06042361 -
Enhancing Equity in Smoke-free Housing
|
N/A | |
Recruiting |
NCT04827420 -
Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)
|
N/A | |
Recruiting |
NCT04994444 -
Preloading With Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts
|
Phase 2/Phase 3 | |
Completed |
NCT05560243 -
Tobacco Cessation Tailored to Patients Living With HIV (PLWH) in Brazil
|
N/A | |
Completed |
NCT02721082 -
Changing the Default for Tobacco Treatment
|
Phase 4 | |
Completed |
NCT01885221 -
A Multi-Media Approach to Partner Support in Smokeless Tobacco Cessation (UCare-ChewFree)
|
N/A | |
Completed |
NCT03445507 -
Effectiveness of a Chat Bot for Smoking Cessation: a Pragmatic Trial in Primary Care.
|
N/A | |
Completed |
NCT04540081 -
Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer
|
N/A | |
Completed |
NCT03714191 -
Optimizing the Tobacco Cessation Clinical Decision Support Tool.
|
||
Completed |
NCT03553992 -
An Extended Facebook Intervention for Young Sexual and Gender Minority Smokers
|
N/A | |
Completed |
NCT01699828 -
Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET
|
Phase 1/Phase 2 | |
Completed |
NCT01328431 -
Treating Low-Income Smokers in the Hospital Emergency Department
|
N/A |